Exponent Inc. (NASDAQ:EXPO) issued its quarterly earnings results on Wednesday. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.08. Exponent had a return on equity of 16.02% and a net margin of 15.13%. The company had revenue of $77.60 million for the quarter, compared to analysts’ expectations of $74.46 million. During the same period last year, the firm earned $0.43 EPS. The firm’s revenue for the quarter was down .4% on a year-over-year basis.
Exponent (NASDAQ:EXPO) traded up 1.38% during midday trading on Wednesday, hitting $50.12. The stock had a trading volume of 173,232 shares. The company has a market cap of $1.30 billion, a P/E ratio of 28.64 and a beta of 0.85. Exponent has a one year low of $44.82 and a one year high of $59.71. The stock’s 50-day moving average is $50.01 and its 200-day moving average is $51.89.
In other Exponent news, insider Paul Boehm sold 5,000 shares of the company’s stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $52.18, for a total transaction of $260,900.00. Following the completion of the sale, the insider now owns 24,045 shares in the company, valued at approximately $1,254,668.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.50% of the stock is currently owned by corporate insiders.
Hedge funds have recently modified their holdings of the stock. Advisor Group Inc. acquired a new stake in shares of Exponent during the second quarter valued at approximately $107,000. ProShare Advisors LLC acquired a new stake in shares of Exponent during the second quarter valued at approximately $217,000. Clinton Group Inc. acquired a new stake in shares of Exponent during the second quarter valued at approximately $317,000. BlackRock Inc. boosted its stake in shares of Exponent by 7.3% in the second quarter. BlackRock Inc. now owns 6,971 shares of the company’s stock valued at $407,000 after buying an additional 473 shares during the last quarter. Finally, BlackRock Advisors LLC boosted its stake in shares of Exponent by 1.7% in the second quarter. BlackRock Advisors LLC now owns 12,284 shares of the company’s stock valued at $718,000 after buying an additional 204 shares during the last quarter. Institutional investors own 91.57% of the company’s stock.
EXPO has been the topic of several research analyst reports. Zacks Investment Research cut Exponent from a “buy” rating to a “hold” rating in a research report on Tuesday, June 21st. Avondale Partners initiated coverage on Exponent in a research report on Thursday, July 7th. They set a “market perform” rating and a $60.00 price target on the stock. Finally, Cantor Fitzgerald initiated coverage on Exponent in a research report on Friday, August 26th. They set a “buy” rating and a $57.00 price target on the stock.
Exponent Company Profile
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.